M&A Deal Summary

DiscoveRx Acquires BioSeek

On November 7, 2012, DiscoveRx acquired life science company BioSeek from Asterand Bioscience

Acquisition Highlights
  • This is DiscoveRx’s 1st transaction in the Life Science sector.
  • This is DiscoveRx’s 1st transaction in the United States.
  • This is DiscoveRx’s 1st transaction in California.

M&A Deal Summary

Date 2012-11-07
Target BioSeek
Sector Life Science
Buyer(s) DiscoveRx
Sellers(s) Asterand Bioscience
Deal Type Divestiture
Advisor(s) Covington Associates (Financial)

Target

BioSeek

South San Francisco, California, United States
BioSeek is a pharmaceutical services.

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DiscoveRx

Fremont, California, United States

Category Company
Sector Life Science
Employees137
DESCRIPTION

DiscoveRx Corp. is an innovative company that develops, manufactures, and commercializes reagents, complete cell-based assay kits, profiling and screening services as well as other disruptive solutions for the drug discovery, screening, and life science markets. EFC technology is a proven, established screening platform in most major pharmaceutical companies. With over 900 stable cell lines, 4500 drug discovery assays and kits, and both custom and off-the shelf services, DiscoverX is one of the most trusted and utilized drug discovery portfolios in the world.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2012 M&A 1 of 1

Seller(S) 1

SELLER

Asterand Bioscience

Detroit, Michigan, United States

Category Company
Sector Life Science
DESCRIPTION

Asterand Bioscience is a provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.


DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Divestiture M&A Deals 1 of 2
State: California M&A 1 of 1
Country: United States M&A 1 of 2
Year: 2012 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-02-18 BioSeek

South San Francisco, California, United States

BioSeek is a pharmaceutical services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-09 Stemgent - iPS Cell Business Unit

United States

iPS cell research reagent products including mRNA reprogramming kit, xeno-free culture media, and specialty chemicals for cell differentiation, and has established a world-famous, proven and trusted brand in the iPS cell field.

Sell -